Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
PLoS One ; 16(6): e0252004, 2021.
Article in English | MEDLINE | ID: mdl-34101737

ABSTRACT

OBJECTIVE: To characterize the microbial communities of the anterior nares (nose) and posterior pharynx (throat) of adults dwelling in the community and in nursing homes before and after treatment with intranasal mupirocin. METHODS: Staphylococcus aureus-colonized adults were recruited from the community (n = 25) and from nursing homes (n = 7). S. aureus colonization was confirmed using cultures. Participants had specimens taken from nose and throat for S. aureus quantitation using quantitative PCR for the nuc gene and bacterial profiling using 16S rRNA gene sequencing over 12 weeks. After two baseline study visits 4 weeks apart, participants received intranasal mupirocin for 5 days with 3 further visits over a 8 week follow-up period. RESULTS: We found a decrease in the absolute abundance of S. aureus in the nose for 8 weeks after mupirocin (1693 vs 141 fg/ul, p = 0.047). Mupirocin caused a statistically significant disruption in bacterial communities of the nose and throat after 1 week, which was no longer detected after 8 weeks. Bacterial community profiling demonstrated that there was a decrease in the relative abundance of S. aureus (8% vs 0.3%, p<0.01) 8 weeks after mupirocin and a transient decrease in the relative abundance of Staphylococcus epidermidis in the nose (21% vs 5%, p<0.01) 1 week after mupirocin. CONCLUSIONS: Decolonization with mupirocin leads to a sustained effect on absolute and relative abundance of S. aureus but not for other bacteria in the nose. This demonstrates that a short course of mupirocin selectively decreases S. aureus in the nose for up to 8 weeks.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Microbiota/drug effects , Mupirocin/therapeutic use , Nose/microbiology , Pharynx/microbiology , Staphylococcal Infections/prevention & control , Administration, Intranasal , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Female , Homes for the Aged , Humans , Male , Middle Aged , Mupirocin/pharmacology , Nursing Homes , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects
2.
Genome Announc ; 5(40)2017 Oct 05.
Article in English | MEDLINE | ID: mdl-28983003

ABSTRACT

Here, we report the complete genome sequence of Bifidobacterium pseudolongum strain UMB-MBP-01, isolated from the feces of C57BL/6J mice. This strain was identified in microbiome profiling studies and associated with improved transplant outcome in a murine model of cardiac heterotypic transplantation.

SELECTION OF CITATIONS
SEARCH DETAIL
...